Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease
Condition: Alzheimer Disease Interventions: Drug: Nilotinib BE 84mg; Drug: Nilotinib BE 112 mg; Drug: Placebo Sponsors: KeifeRx, LLC; Worldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials